Description
DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES
First action · last action
2018-10-01 · 2024-05-07
Transactions
11
First transaction's obligation
$450,000
Base + all options value (sum of deltas)
$1,604,847
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-10-01+$450,000= $450,000
- Mod P000012019-05-28-$30,000= $420,000
- Mod P000022019-09-28+$420,000= $840,000
- Mod P000032020-09-15-$80,660= $759,340
- Mod P000042020-10-01+$375,000= $1,134,340
- Mod P000052021-09-02-$152,774= $981,566
- Mod P000062021-10-01+$364,000= $1,345,566
- Mod P000082021-12-02-$102,090= $1,243,477
- Mod P000092022-10-01+$425,000= $1,668,477
- Mod P000102023-05-16-$27,562= $1,640,914
- Mod P000112024-05-07-$36,068= $1,604,847
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-10-01 | +$450,000 | $450,000 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00001· CHANGE ORDER | 2019-05-28 | −$30,000 | $420,000 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00002· EXERCISE AN OPTION | 2019-09-28 | +$420,000 | $840,000 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-09-15 | −$80,660 | $759,340 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00004· EXERCISE AN OPTION | 2020-10-01 | +$375,000 | $1,134,340 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-09-02 | −$152,774 | $981,566 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00006· EXERCISE AN OPTION | 2021-10-01 | +$364,000 | $1,345,566 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-02 | −$102,090 | $1,243,477 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00009· EXERCISE AN OPTION | 2022-10-01 | +$425,000 | $1,668,477 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-05-16 | −$27,562 | $1,640,914 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-05-07 | −$36,068 | $1,604,847 | DAILY FORMULATION AND DELIVERY OF RADIOISOTOPES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24526N0840 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $19,139 | FY2026 |
| 36C24526N0839 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $38,360 | FY2026 |
| 36C24526N0837 | QOL MEDICAL LLC | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,945 | FY2026 |
| 36C24526N0835 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $34,605 | FY2026 |
| 36C24526N0834 | GALDERMA LABORATORIES, L.P. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,960 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24519C0083_3600_-NONE-_-NONE- · retrieved 2026-09-26.